CCL21 and neoplasm: Based on the promising results of extensive pre-clinical testing of intratumoral DC-CCL21 in murine tumor models, a phase 1 clinical trial of DC-CCL21 was initiated in late stage non-small cell lung cancer patients at University of California Los Angeles.